 |
 Previous Article | Next Article 
Volume 17, Number 18,
Issue of September 15, 1997
pp. 7157-7165
Copyright ©1997 Society for Neuroscience
The  2a Adrenergic Receptor Subtype Mediates Spinal
Analgesia Evoked by 2 Agonists and Is Necessary for
Spinal Adrenergic-Opioid Synergy
Received April 18, 1997; revised June 25, 1997; accepted July 8, 1997.
Laura S. Stone1, 2,
Leigh B. MacMillan3,
Kelley
F. Kitto2,
Lee E. Limbird3, and
George L. Wilcox1, 2
1 Graduate Program in Neuroscience and
2 Department of Pharmacology, University of Minnesota,
Minneapolis, Minnesota 55455, and 3 Department of
Pharmacology, Vanderbilt University, Nashville, Tennessee 37232
Agonists acting at  2 adrenergic and opioid
receptors have analgesic properties and act synergistically when
co-administered in the spinal cord; this synergy may also contribute to
the potency and efficacy of spinally administered morphine. The lack of
subtype-selective pharmacological agents has previously impeded the
definition of the adrenergic receptor subtype(s) mediating these
effects. We therefore exploited a genetically modified mouse line
expressing a point mutation (D79N) in the 2a adrenergic
receptor (2aAR) to investigate the role of the
2aAR in 2 agonist-evoked analgesia and
adrenergic-opioid synergy. In the tail-flick test, intrathecal administration of UK 14,304, a nonsubtype-selective 2AR
agonist, had no analgesic effect in D79N mice, whereas the analgesic
potency of morphine (intrathecal) in this assay was not
affected by the mutation. The mutation also decreased
2-agonist-mediated spinal analgesia and blocked the
synergy seen in wild-type mice with both the  -opioid agonist
deltorphin II and the µ-opioid agonist [D-ALA2,N-Me-Phe4,Gly-ol5]-Enkephalin
(DAMGO) in the substance P behavioral test. In addition, the potency of
spinally administered morphine was decreased in this test, suggesting
that activation of descending noradrenergic systems impinging on the
2aAR contributes to morphine-induced spinal inhibition
in this model. These results demonstrate that the 2aAR
subtype is the primary mediator of 2 adrenergic spinal
analgesia and is necessary for analgesic synergy with opioids. Thus,
combination therapies targeting the 2aAR and opioid
receptors may prove useful in maximizing the analgesic efficacy of
opioids while decreasing total dose requirements.
Key words:
2 adrenergic receptor;
synergy;
mice;
morphine;
antinociception;
intrathecal;
substance P;
opioid;
isobologram;
gene targeting;
2aAR
This article has been cited by other articles:
|
|
|
|
 
M. Tan, W. M. Walwyn, C. J. Evans, and C.-W. Xie
p38 MAPK and {beta}-Arrestin 2 Mediate Functional Interactions between Endogenous {micro}-Opioid and {alpha}2A-Adrenergic Receptors in Neurons
J. Biol. Chem.,
March 6, 2009;
284(10):
6270 - 6281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Y. Chung and S. Bruehl
The Impact of Blood Pressure and Baroreflex Sensitivity on Wind-Up
Anesth. Analg.,
September 1, 2008;
107(3):
1018 - 1025.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Stone, K. F. Kitto, J. C. Eisenach, C. A. Fairbanks, and G. L. Wilcox
ST91 [2-(2,6-Diethylphenylamino)-2-imidazoline Hydrochloride]-Mediated Spinal Antinociception and Synergy with Opioids Persists in the Absence of Functional {alpha}-2A- or {alpha}-2C-Adrenergic Receptors
J. Pharmacol. Exp. Ther.,
December 1, 2007;
323(3):
899 - 906.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Basile, A. Janowsky, K. Golembiowska, M. Kowalska, E. Tam, M. Benveniste, P. Popik, A. Nikiforuk, M. Krawczyk, G. Nowak, et al.
Characterization of the Antinociceptive Actions of Bicifadine in Models of Acute, Persistent, and Chronic Pain
J. Pharmacol. Exp. Ther.,
June 1, 2007;
321(3):
1208 - 1225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sonohata, H. Furue, T. Katafuchi, T. Yasaka, A. Doi, E. Kumamoto, and M. Yoshimura
Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording
J. Physiol.,
March 1, 2004;
555(2):
515 - 526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Olave and D. J. Maxwell
Neurokinin-1 Projection Cells in the Rat Dorsal Horn Receive Synaptic Contacts from Axons That Possess {alpha}2C-Adrenergic Receptors
J. Neurosci.,
July 30, 2003;
23(17):
6837 - 6846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Bohn, R. J. Lefkowitz, and M. G. Caron
Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in beta Arrestin-2 Knock-Out Mice
J. Neurosci.,
December 1, 2002;
22(23):
10494 - 10500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Tan, M. H. Wilson, L. B. MacMillan, B. K. Kobilka, and L. E. Limbird
Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
PNAS,
September 17, 2002;
99(19):
12471 - 12476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Philipp, M. Brede, and L. Hein
Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2002;
283(2):
R287 - R295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Jasmin, D. Tien, D. Weinshenker, R. D. Palmiter, P. G. Green, G. Janni, and P. T. Ohara
The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline
PNAS,
January 22, 2002;
99(2):
1029 - 1034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Fairbanks, L. S. Stone, K. F. Kitto, H. O. Nguyen, I. J. Posthumus, and G. L. Wilcox
alpha 2C-Adrenergic Receptors Mediate Spinal Analgesia and Adrenergic-Opioid Synergy
J. Pharmacol. Exp. Ther.,
January 1, 2002;
300(1):
282 - 290.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Li and J. C. Eisenach
alpha 2A-Adrenoceptor Stimulation Reduces Capsaicin-Induced Glutamate Release from Spinal Cord Synaptosomes
J. Pharmacol. Exp. Ther.,
December 1, 2001;
299(3):
939 - 944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pare, R. Elde, J. E. Mazurkiewicz, A. M. Smith, and F. L. Rice
The Meissner Corpuscle Revised: A Multiafferented Mechanoreceptor with Nociceptor Immunochemical Properties
J. Neurosci.,
September 15, 2001;
21(18):
7236 - 7246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Bohn, F. Xu, R. R. Gainetdinov, and M. G. Caron
Potentiated Opioid Analgesia in Norepinephrine Transporter Knock-Out Mice
J. Neurosci.,
December 15, 2000;
20(24):
9040 - 9045.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sawamura, W. S. Kingery, M. F. Davies, G. S. Agashe, J. D. Clark, B. K. Kobilka, T. Hashimoto, and M. Maze
Antinociceptive Action of Nitrous Oxide Is Mediated by Stimulation of Noradrenergic Neurons in the Brainstem and Activation of {alpha}2B Adrenoceptors
J. Neurosci.,
December 15, 2000;
20(24):
9242 - 9251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Kable, L. C. Murrin, and D. B. Bylund
In Vivo Gene Modification Elucidates Subtype-Specific Functions of alpha 2-Adrenergic Receptors
J. Pharmacol. Exp. Ther.,
April 1, 2000;
293(1):
1 - 7.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. A. Chotani, S. Flavahan, S. Mitra, D. Daunt, and N. A. Flavahan
Silent alpha 2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries
Am J Physiol Heart Circ Physiol,
April 1, 2000;
278(4):
H1075 - H1083.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Olli-Lahdesmaki, J. Kallio, and M. Scheinin
Receptor Subtype-Induced Targeting and Subtype-Specific Internalization of Human alpha 2-Adrenoceptors in PC12 Cells
J. Neurosci.,
November 1, 1999;
19(21):
9281 - 9288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Fairbanks and G. L. Wilcox
Moxonidine, a Selective alpha 2-Adrenergic and Imidazoline Receptor Agonist, Produces Spinal Antinociception in Mice
J. Pharmacol. Exp. Ther.,
July 1, 1999;
290(1):
403 - 412.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
S. A. Aicher and C. T. Drake
Clonidine Evokes Vasodepressor Responses via alpha 2-Adrenergic Receptors in Gigantocellular Reticular Formation
J. Pharmacol. Exp. Ther.,
May 1, 1999;
289(2):
688 - 694.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K.-M. Zhang, X.-M. Wang, A. M. Peterson, W.-Y. Chen, and S. S. Mokha
alpha 2-Adrenoceptors Modulate NMDA-Evoked Responses of Neurons in Superficial and Deeper Dorsal Horn of the Medulla
J Neurophysiol,
October 1, 1998;
80(4):
2210 - 2214.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Stone, C. Broberger, L. Vulchanova, G. L. Wilcox, T. Hokfelt, M. S. Riedl, and R. Elde
Differential Distribution of alpha 2A and alpha 2C Adrenergic Receptor Immunoreactivity in the Rat Spinal Cord
J. Neurosci.,
August 1, 1998;
18(15):
5928 - 5937.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sallinen, A. Haapalinna, T. Viitamaa, B. K. Kobilka, and M. Scheinin
Adrenergic alpha 2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
J. Neurosci.,
April 15, 1998;
18(8):
3035 - 3042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
